The Safety and Efficacy of Absnow Fully Biodegradable Atrial Septal Defect Occluder: A Prospective, Single‐Center Phase III Clinical Trial
This study further confirmed the short-to-mid-term safety and acceptable efficacy of the Absnow fully biodegradable atrial septal occluder based on a 4-year follow-up. The late-occurring residual shunts with device degradation have an important impact on its long-term efficacy.
Authors
- Piaohong Liang
- Shiqiang Fan
- C Liu
- Wei Wang (ORCID: https://orcid.org/0000-0003-1537-8471)
- Ying Xie (ORCID: https://orcid.org/0000-0002-8856-4243)
- Boning Li (ORCID: https://orcid.org/0000-0003-0924-9673)
- Zhenheng Ou (ORCID: https://orcid.org/0000-0002-0843-1476)
- Meng Li
Institutions
- Shenzhen Children's Hospital (CN)
Publication Details
- Journal
- Clinical Cardiology
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1002/clc.70262
- Primary Topic
- Cardiovascular and Diving-Related Complications
- Type
- article
- Field-Weighted Citation Impact
- 0.00